ChemoMetec 미래 성장

Future 기준 확인 4/6

ChemoMetec (는) 각각 연간 17.2% 및 14.3% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 17.1% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 26.8% 로 예상됩니다.

주요 정보

17.2%

수익 성장률

17.1%

EPS 성장률

Life Sciences 수익 성장	26.4%
매출 성장률	14.3%
향후 자기자본 수익률	26.8%
애널리스트 커버리지	Low
마지막 업데이트	11 Nov 2024

최근 미래 성장 업데이트

Recent updates

ChemoMetec A/S (CPH:CHEMM) Stock Rockets 32% As Investors Are Less Pessimistic Than Expected

Nov 09

We Think That There Are More Issues For ChemoMetec (CPH:CHEMM) Than Just Sluggish Earnings

Sep 18

What ChemoMetec A/S' (CPH:CHEMM) 27% Share Price Gain Is Not Telling You

Jul 29

Earnings Not Telling The Story For ChemoMetec A/S (CPH:CHEMM) After Shares Rise 27%

Jul 29

Earnings Beat: ChemoMetec A/S Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 08

Unpleasant Surprises Could Be In Store For ChemoMetec A/S' (CPH:CHEMM) Shares

Dec 21

Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?

Nov 15

ChemoMetec A/S (CPH:CHEMM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Sep 17

A Look At The Intrinsic Value Of ChemoMetec A/S (CPH:CHEMM)

Sep 15

At kr.467, Is ChemoMetec A/S (CPH:CHEMM) Worth Looking At Closely?

Jun 20

With EPS Growth And More, ChemoMetec (CPH:CHEMM) Makes An Interesting Case

Jun 01

Here's Why ChemoMetec (CPH:CHEMM) Has Caught The Eye Of Investors

Jan 24

If EPS Growth Is Important To You, ChemoMetec (CPH:CHEMM) Presents An Opportunity

Oct 26

Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?

Oct 05

Does ChemoMetec (CPH:CHEMM) Deserve A Spot On Your Watchlist?

Jul 18

Here's Why I Think ChemoMetec (CPH:CHEMM) Is An Interesting Stock

Mar 27

Do ChemoMetec's (CPH:CHEMM) Earnings Warrant Your Attention?

Dec 12

수익 및 매출 성장 예측

CPSE:CHEMM - 애널리스트의 미래 추정치 및 과거 재무 데이터 (DKK Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
6/30/2027	629	234	185	249	3
6/30/2026	547	202	164	219	3
6/30/2025	475	175	158	205	3
6/30/2024	408	136	85	129	N/A
3/31/2024	405	140	98	138	N/A
12/31/2023	402	144	111	147	N/A
9/30/2023	423	161	112	150	N/A
6/30/2023	444	179	113	154	N/A
3/31/2023	453	179	117	156	N/A
12/31/2022	461	180	120	158	N/A
9/30/2022	445	170	120	167	N/A
6/30/2022	428	159	121	177	N/A
3/31/2022	393	145	94	148	N/A
12/31/2021	358	131	67	119	N/A
9/30/2021	320	110	75	114	N/A
6/30/2021	281	88	83	108	N/A
3/31/2021	262	81	79	105	N/A
12/31/2020	243	74	75	103	N/A
9/30/2020	229	67	60	87	N/A
6/30/2020	214	59	45	72	N/A
3/31/2020	206	54	39	66	N/A
12/31/2019	197	48	32	61	N/A
9/30/2019	186	45	32	60	N/A
6/30/2019	176	42	31	58	N/A
3/31/2019	158	37	26	50	N/A
12/31/2018	141	33	21	42	N/A
9/30/2018	127	25	15	34	N/A
6/30/2018	113	18	9	25	N/A
3/31/2018	107	15	N/A	20	N/A
12/31/2017	102	13	N/A	14	N/A
9/30/2017	96	10	N/A	12	N/A
6/30/2017	90	7	N/A	10	N/A
3/31/2017	88	6	N/A	13	N/A
12/31/2016	85	5	N/A	16	N/A
9/30/2016	85	8	N/A	17	N/A
6/30/2016	85	10	N/A	17	N/A
3/31/2016	80	11	N/A	16	N/A
12/31/2015	75	12	N/A	14	N/A
9/30/2015	68	10	N/A	14	N/A
6/30/2015	61	8	N/A	13	N/A
3/31/2015	56	5	N/A	9	N/A
12/31/2014	51	3	N/A	5	N/A
9/30/2014	48	2	N/A	5	N/A
6/30/2014	45	1	N/A	6	N/A
3/31/2014	44	1	N/A	6	N/A
12/31/2013	43	1	N/A	6	N/A

애널리스트 미래 성장 예측

수입 대 저축률: CHEMM 의 연간 예상 수익 증가율( 17.2% )이 saving rate( 1.2% 보다 높습니다. ).

수익 vs 시장: CHEMM 의 연간 수익( 17.2% ) Danish 시장( 11.6% 보다 빠르게 성장할 것으로 예상됩니다. 11.6% 연간).

고성장 수익: CHEMM 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: CHEMM 의 수익(연간 14.3% ) Danish 시장( 10% 보다 빠르게 성장할 것으로 예상됩니다. 10% 연간).

고성장 수익: CHEMM 의 수익(연간 14.3% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: CHEMM 의 자본 수익률은 3년 내에 최고 수준이 될 것으로 예상됩니다. ( 26.8 %)

ChemoMetec 미래 성장

Future 기준 확인 4/6

주요 정보

최근 미래 성장 업데이트

Price target increased by 15% to kr.505

Consensus EPS estimates increase by 11%

ChemoMetec A/S Maintains Earnings Guidance for the Full-Year 2024-2025

ChemoMetec A/S Revises Earnings Guidance for the Financial Year 2024/2025

Price target increased by 8.0% to kr.473

ChemoMetec A/S provides earnings guidance for the year 2024/25

Recent updates

Deputy Chairman & Senior Advisor recently bought kr.3.2m worth of stock

Price target increased by 15% to kr.505

Consensus EPS estimates increase by 11%

ChemoMetec A/S (CPH:CHEMM) Stock Rockets 32% As Investors Are Less Pessimistic Than Expected

New major risk - Share price stability

ChemoMetec A/S Maintains Earnings Guidance for the Full-Year 2024-2025

Investor sentiment improves as stock rises 19%

Insufficient new directors

ChemoMetec A/S (CPSE:CHEMM) completed the acquisition of Ovizio Imaging Systems NV/SA.

ChemoMetec A/S Revises Earnings Guidance for the Financial Year 2024/2025

ChemoMetec A/S Approves Dividend

Upcoming dividend of kr.4.00 per share

ChemoMetec A/S (CPSE:CHEMM) submitted an indicative offer to acquire Ovizio Imaging Systems NV/SA.

We Think That There Are More Issues For ChemoMetec (CPH:CHEMM) Than Just Sluggish Earnings

Dividend of kr.4.00 announced

Price target increased by 8.0% to kr.473

Full year 2024 earnings: EPS exceeds analyst expectations

ChemoMetec A/S provides earnings guidance for the year 2024/25

Investor sentiment improves as stock rises 17%

ChemoMetec A/S to Report Fiscal Year 2025 Results on Sep 11, 2025

What ChemoMetec A/S' (CPH:CHEMM) 27% Share Price Gain Is Not Telling You

Earnings Not Telling The Story For ChemoMetec A/S (CPH:CHEMM) After Shares Rise 27%

Investor sentiment improves as stock rises 15%

What Is ChemoMetec A/S's (CPH:CHEMM) Share Price Doing?

ChemoMetec A/S Announces CFO Changes

Independent Director recently bought kr.450k worth of stock

Investor sentiment improves as stock rises 17%

Now 20% overvalued

Price target increased by 14% to kr.513

Now 21% overvalued

Some Confidence Is Lacking In ChemoMetec A/S (CPH:CHEMM) As Shares Slide 32%

ChemoMetec A/S Provides Earnings Guidance for the Year 2023/24

Investor sentiment deteriorates as stock falls 18%

Investor sentiment deteriorates as stock falls 16%

ChemoMetec A/S Announces CEO Changes

What ChemoMetec A/S' (CPH:CHEMM) 30% Share Price Gain Is Not Telling You

What Does ChemoMetec A/S's (CPH:CHEMM) Share Price Indicate?

Investor sentiment improves as stock rises 30%

Earnings Beat: ChemoMetec A/S Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

First half 2024 earnings: EPS and revenues exceed analyst expectations

New major risk - Share price stability

ChemoMetec A/S Maintains Earnings Guidance for the Year 2024

Price target decreased by 18% to kr.448

ChemoMetec A/S Announces Executive Changes

Unpleasant Surprises Could Be In Store For ChemoMetec A/S' (CPH:CHEMM) Shares

Investor sentiment improves as stock rises 30%

Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?

Investor sentiment improves as stock rises 17%

Upcoming dividend of kr.6.00 per share at 1.8% yield

ChemoMetec A/S (CPH:CHEMM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

A Look At The Intrinsic Value Of ChemoMetec A/S (CPH:CHEMM)

Chemometec A/S Proposes Dividend for the 2022/23 Financial Year

Full year 2023 earnings: EPS and revenues miss analyst expectations

New minor risk - Financial data availability

ChemoMetec A/S to Report Fiscal Year 2024 Results on Sep 11, 2024

At kr.467, Is ChemoMetec A/S (CPH:CHEMM) Worth Looking At Closely?

With EPS Growth And More, ChemoMetec (CPH:CHEMM) Makes An Interesting Case

ChemoMetec A/S Affirms Earnings Guidance for the Fiscal Year 2022/2023

First half 2023 earnings released: EPS: kr.6.06 (vs kr.4.90 in 1H 2022)

Investor sentiment deteriorates as stock falls 20%

ChemoMetec A/S Updates Earnings Guidance for the Fiscal Year 2022/2023

Here's Why ChemoMetec (CPH:CHEMM) Has Caught The Eye Of Investors

Investor sentiment deteriorated over the past week

Chemometec A/S Announces Resignation of Steen Søndergaard as CEO

Less than half of directors are independent

ChemoMetec A/S Provides Earnings Guidance for the Financial Year 2022-23

If EPS Growth Is Important To You, ChemoMetec (CPH:CHEMM) Presents An Opportunity

Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?

Investor sentiment deteriorated over the past week